PTC Therapeutics, Inc. (NASDAQ:PTCT) Expected to Post Quarterly Sales of $105.65 Million

Retrieved on: 2021-07-13 09:00:00

Tags for this article:

Click the tags to see associated articles and topics

PTC Therapeutics, Inc. (NASDAQ:PTCT) Expected to Post Quarterly Sales of $105.65 Million. View article details on hiswai:

Excerpt

Millennium Management LLC now owns 150,778 shares of the biopharmaceutical company's stock valued at $7,139,000 after buying an additional ...

Article found on: www.marketbeat.com